SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about disclosure

15 Jan 2026 Evaluate

In terms of Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare has informed that Koanna Healthcare Canada Inc., a Wholly Owned Subsidiary of the Company, has on 14 January 2026, allotted 2,84,21,020 shares equity shares aggregating to a total consideration of CAD 2000 pursuant to a Share Sale-Purchase Agreement, in favour of Steve N. Slilaty, an individual residing at Québec, Canada. The company has already provided for the above investment in the subsidiary. Hence, there is no impact on the Company’s current financials. Consequent to the above transaction, Koanna Healthcare Canada Inc. has ceased to be a wholly owned subsidiary of the Company with effect from 14 January 2026. Further, Koanna Healthcare Canada Inc. was not a material subsidiary of the Company, as defined under Regulation 16 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details as required under Clause 1 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P /0155 dated 11th November 2024 (as amended) are provided in Annexure A. The same is also available on the Company’s website at https://www.vbshilpa.com/.

The above information is a part of company’s filings submitted to BSE.


Shilpa Medicare Share Price

410.70 -0.85 (-0.21%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×